STOCK TITAN

Enovis Corporation Form 4 Filings

ENOV NYSE

Every Form 4 that Enovis Corporation (ENOV) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A Form 4 covers the transactions officers, directors and large holders report, so if you follow ENOV and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full ENOV filings page.

Rhea-AI Summary

Enovis Corp director Christine Ortiz acquired 958 shares of common stock through a grant or award on September 30, 2026. The transaction price was reported as $0.0000 per share. Her directly held common-stock position following the transaction was 26,815 shares.

Rhea-AI Summary

Enovis CORP (ENOV) reported that Chief Administrative Officer Oliver Engert purchased common stock in the open market. On September 4, 2026, he bought 2,660 shares of common stock at a weighted average price of $18.80 per share, in multiple trades between $18.74 and $18.85. Following this transaction, he directly holds 63,898 shares of Enovis common stock.

Rhea-AI Summary

Enovis CORP (ENOV) reported that Chief Administrative Officer Oliver Engert purchased a total of 7,598 shares of Enovis common stock in open market or private transactions on September 2 and 3, 2026. The reported weighted average prices were $20.32 and $19.46 per share, based on multiple trades within disclosed price ranges, and no Rule 10b5-1 trading plan is reported.

Rhea-AI Summary

Enovis CORP (ENOV) reported that Chief Executive Officer and director Damien McDonald purchased 13,035 shares of common stock on September 4, 2026 in an open-market transaction at a weighted average price of $19.15 per share, with individual trade prices ranging from $19.10 to $19.16. Following this purchase, he directly holds 247,077 shares of Enovis common stock. No Rule 10b5-1 trading plan is reported for this transaction.

Rhea-AI Summary

Ortiz Christine reported acquisition or exercise transactions in this Form 4 filing.

Enovis CORP director Christine Ortiz received an equity award of 846 shares of common stock. The shares were granted on June 30, 2026 at a stated price of $0.00 per share as a compensation-related award rather than a market purchase.

Following this grant, Ortiz directly holds 25,857 shares of Enovis common stock. This filing records a routine non-derivative stock award to a board member, with no associated open-market buying or selling activity.

Rhea-AI Summary

Enovis CORP Chief Administrative Officer Oliver Engert reported an open-market purchase of 1,000 shares of common stock at $20.92 per share. Following this transaction, he directly owns 53,640 shares of Enovis common stock, increasing his personal stake in the company.

Rhea-AI Summary

Engert Oliver reported acquisition or exercise transactions in this Form 4 filing.

Enovis Corp Chief Administrative Officer Oliver Engert reported an amended insider transaction showing a grant of 1,000 shares of common stock at $20.99 per share. The filing updates his direct holdings to 52,640 shares. The amendment corrects clerical errors in the original Form 4; no other changes were made.

Rhea-AI Summary

Enovis CORP Chief Administrative Officer Oliver Engert bought additional company stock in the open market. He made two open-market purchases of Enovis common stock, totaling 1,200 shares. One trade was for 1,000 shares at $21.75 per share and another for 200 shares at $20.99 per share. These are direct ownership purchases, indicating he increased his personal stake in the company.

Rhea-AI Summary

Enovis CORP Chief Administrative Officer Oliver Engert bought 1,000 shares of common stock in an open-market purchase at $23.00 per share on June 10, 2026. After this transaction, he directly owns 50,640 Enovis shares, modestly increasing his personal stake in the company.

Rhea-AI Summary

Enovis CORP Chief Administrative Officer Oliver Engert purchased additional company stock in the open market. He bought 1,000 shares of common stock at a price of $22.22 per share. After this transaction, he directly owns a total of 49,640 shares of Enovis common stock.

Rhea-AI Summary

Shirley Brady reported acquisition or exercise transactions in this Form 4 filing.

Enovis CORP director Shirley Brady received a grant of 9,346 shares of common stock on May 19, 2026. The shares were awarded at no stated price as compensation rather than a market purchase. After this award, Brady directly holds a total of 110,589 Enovis common shares.

Rhea-AI Summary

Bodem Barbara W. reported acquisition or exercise transactions in this Form 4 filing.

Enovis Corp director Barbara W. Bodem received an equity award of 9,346 shares of common stock on May 19, 2026. The shares were granted at no cash cost to her, reflecting stock-based compensation rather than an open-market purchase. After this award, she directly owns 24,201 Enovis common shares.

Rhea-AI Summary

Enovis CORP director Philip Okala received a grant of 9,346 shares of common stock. The award was recorded on May 19, 2026 at a stated price of $0.00 per share, indicating it was a compensation-related equity grant rather than an open-market purchase.

After this grant, Okala directly holds a total of 24,201 shares of Enovis common stock. The filing does not show any share sales, option exercises, or derivative positions; it only reports this single stock award and the resulting direct ownership level.

Rhea-AI Summary

Ortiz Christine reported acquisition or exercise transactions in this Form 4 filing.

Enovis Corp director Christine Ortiz received a grant of company stock. On May 19, 2026, she was awarded 9,346 shares of Enovis common stock at no purchase price as a compensation-related grant. After this award, she directly owns 25,011 common shares of Enovis.

This was a stock grant, not an open-market purchase or sale, and reflects routine equity-based compensation rather than a discretionary trade in the market.

Rhea-AI Summary

Lalor Angela S reported acquisition or exercise transactions in this Form 4 filing.

Enovis CORP director Angela S. Lalor received a stock grant of 9,346 shares of common stock on May 19, 2026. The award was recorded at a price of $0.00 per share, indicating a compensation-related grant rather than an open-market purchase. Following this grant, she directly holds 31,486 Enovis common shares.

Rhea-AI Summary

PERFALL A CLAYTON reported acquisition or exercise transactions in this Form 4 filing.

Enovis CORP director A. Clayton Perfall reported a stock grant and updated holdings. The filing shows a grant or award of 9,346 shares of common stock at no cash cost, bringing his directly held stake to 54,190 shares. A separate entry reports indirect ownership of 2,482 shares held by a trust.

The transactions are compensation and ownership updates rather than open-market buying or selling, so they mainly clarify the director’s equity position in Enovis.

Rhea-AI Summary

Kelly Liam reported acquisition or exercise transactions in this Form 4 filing.

Enovis CORP director Liam Kelly received a grant of 9,346 shares of common stock. The award was reported at a price of $0.00 per share, indicating it was a compensation-related grant rather than an open-market purchase. Following this grant, Kelly directly holds a total of 28,950 Enovis common shares.

Rhea-AI Summary

Wienbar Sharon L reported acquisition or exercise transactions in this Form 4 filing.

Enovis CORP director Sharon L. Wienbar received a grant of 9,346 shares of common stock on May 19, 2026. The shares were awarded at a stated price of $0.00 per share, indicating a compensation-related grant rather than an open-market purchase. Following this award, she directly holds 41,946 shares of Enovis common stock.

Rhea-AI Summary

Vinnakota Rajiv reported acquisition or exercise transactions in this Form 4 filing.

Enovis CORP director Rajiv Vinnakota received a grant of 9,346 shares of common stock on May 19, 2026 at no cost as an equity award. This increased his directly held stake to 37,608 shares. The transaction reflects routine stock-based compensation, not an open-market purchase or sale.

Rhea-AI Summary

Enovis CORP Chief Executive Officer Damien McDonald reported a routine tax-related share disposition. On May 12, 2026, 12,634 shares of common stock at $25.99 per share were withheld by the company to satisfy tax obligations tied to net-settled restricted stock units, and this was not an open-market sale. After this withholding, McDonald directly holds 234,042 shares of Enovis common stock.

Rhea-AI Summary

Enovis CORP SVP and Chief Financial Officer Phillip Ben Berry reported a tax-related share withholding, not an open-market sale. On this Form 4, 7,774 shares of common stock were withheld by the company at $25.99 per share to satisfy tax obligations tied to restricted stock units. After this withholding, Berry directly holds 150,822 shares of Enovis common stock.

Rhea-AI Summary

Enovis CORP director Christine Ortiz received a stock grant that increased her direct ownership. On March 31, 2026, she was granted 770 shares of Enovis common stock at a stated price of $0.00 per share, reflecting a compensation-related award rather than an open-market purchase.

After this grant, Ortiz directly holds 15,665 shares of Enovis common stock. The filing shows no accompanying sales or derivative exercises, so this transaction represents a small, routine increase in her equity stake through non-derivative stock compensation.

Rhea-AI Summary

Enovis Corp’s Chief Administrative Officer, Oliver Engert, made an open-market purchase of company stock. On March 13, 2026, he bought 1,000 shares of Enovis common stock at $23.74 per share. After this transaction, he directly owns 48,640 shares of Enovis common stock.

This was a straightforward open-market buy, increasing his direct equity stake by a relatively small amount compared with his existing holdings.

Rhea-AI Summary

Enovis CORP Chief Administrative Officer Oliver Engert bought 1,000 shares of common stock in an open-market purchase at a weighted average price of $23.93 per share. This increases his directly owned stake to 47,640 common shares.

The filing notes the purchase was executed through multiple trades within a price range from $23.75 to $24.10 per share. The transaction represents a relatively small addition compared with his total reported holdings, suggesting a routine increase in personal investment exposure to the company.

Rhea-AI Summary

Enovis Corp’s principal accounting officer John Kleckner received an equity grant of 14,925 shares of common stock on March 9, 2026. The shares were awarded at no cost as restricted stock units that vest in three equal annual installments beginning on the first anniversary of the grant date.

On March 7, 2026, 586 shares were withheld at $24.51 per share to cover tax obligations tied to a restricted stock unit net settlement, which the company notes is not a sale by Kleckner. Following these transactions, he directly holds 25,884 common shares.

Rhea-AI Summary

Enovis Corp executive Terry D. Ross, Group President, P&R, received a grant of 36,247 shares of common stock in the form of restricted stock units. These RSUs vest in three equal annual installments beginning on the first anniversary of the grant date.

On a related date, 2,376 shares were withheld by the company at $24.5100 per share to cover tax withholding and remittance obligations tied to the net settlement of RSUs; this did not represent an open-market sale. After these transactions, Ross directly holds 68,477 shares of Enovis common stock.

Rhea-AI Summary

Enovis senior vice president and chief HR officer Patricia A. Lang received a grant of 25,586 restricted stock units of common stock on March 9, 2026 at no cash cost. The award vests in three equal annual installments beginning on the first anniversary of the grant date.

On March 7, 2026, 2,969 shares were withheld at $24.51 per share to cover tax obligations from restricted stock unit settlement, which the company states does not represent a sale by Lang. Following these transactions, she directly holds 75,703 shares of Enovis common stock.

Rhea-AI Summary

Enovis CORP Group President, Recon Louis Vogt received an equity award and had shares withheld for taxes. On March 9, 2026, he acquired 36,247 shares of common stock at $0.00 per share as a grant of restricted stock units, bringing his direct holdings to 68,875 shares. On March 7, 2026, 1,980 shares were disposed of at $24.51 per share to cover tax withholding obligations connected to a net settlement of restricted stock units, leaving 32,628 shares following that tax event. A footnote clarifies the 1,980-share disposition was solely to satisfy tax withholding and remittance requirements and does not represent a sale by Vogt. Another footnote states the new restricted stock units vest in three equal annual installments beginning on the first anniversary of the grant date.

Rhea-AI Summary

Enovis CORP senior vice president and chief legal officer Tandy Bradley J received a grant of 25,586 shares of common stock on March 9, 2026 as a compensation award. The award consists of restricted stock units that vest in three equal annual installments beginning on the first anniversary of the grant date. On March 7, 2026, 1,874 shares were withheld by the company at $24.51 per share to satisfy tax withholding and remittance obligations related to net settlement of restricted stock units, and this did not represent an open-market sale. Following these transactions, Bradley directly holds 65,641 shares of Enovis common stock.

Rhea-AI Summary

Enovis CORP senior vice president and CFO Phillip Benjamin (Ben) Berry received an equity grant of 47,974 shares of common stock through restricted stock units. These RSUs vest in three equal annual installments beginning on the first anniversary of the grant date, aligning his compensation with long-term company performance.

In a separate transaction, 3,167 shares were withheld by the company at a price of $24.51 per share to cover tax obligations tied to the net settlement of restricted stock units, which the company states does not represent a sale by Berry. Following these transactions, he holds 158,596 shares of Enovis common stock directly.

Rhea-AI Summary

McDonald Damien reported acquisition or exercise transactions in this Form 4 filing.

Enovis Corp Chief Executive Officer Damien McDonald received an equity award of 143,923 shares of common stock as a grant at no cash cost on the date of grant. This award consists of restricted stock units that vest in three equal annual installments beginning on the first anniversary of the grant date. Following this grant, McDonald directly holds 246,676 shares of Enovis common stock.

Rhea-AI Summary

Enovis Corp Chief Administrative Officer Oliver Engert bought a total of 1,750 shares of common stock in open-market transactions. He purchased 250 shares and 500 shares on March 6, 2026 at prices of $24.28 and $24.48 per share, and 1,000 shares on March 9, 2026 at $23.39 per share. Following these purchases, he directly owns 46,640 shares of Enovis common stock.

Rhea-AI Summary

Enovis CORP senior executive reports tax-related share disposition

Enovis CORP SVP and Chief Legal Officer Bradley J. Tandy reported a Form 4 transaction involving 1,102 shares of common stock on March 4, 2026. The shares were withheld by the company at a price of $25.79 per share to cover tax withholding obligations tied to the net settlement of restricted stock units.

The footnote clarifies this was a tax-withholding disposition and not an open-market sale by the executive. After this transaction, Tandy directly owned 41,929 shares of Enovis common stock.

Rhea-AI Summary

Enovis CORP executive reports tax-related share withholding. Group President, P&R Terry D. Ross reported a disposition of 765 shares of Enovis common stock on March 4, 2026 at $25.79 per share. These shares were withheld by the company to cover tax obligations from the net settlement of restricted stock units and are explicitly described as not representing a sale by the reporting person. After this withholding, Ross directly owns 34,606 shares of Enovis common stock.

Rhea-AI Summary

Enovis Corp principal accounting officer John Kleckner reported a small tax-related share disposition. On the reported date, 442 shares of Enovis common stock at $25.79 per share were withheld by the company to cover tax obligations tied to the net settlement of restricted stock units, which the footnote states does not represent a sale by Kleckner. After this withholding, he held 11,545 shares directly.

Rhea-AI Summary

Enovis CORP director Shirley Brady reported a tax-related share disposition. On March 4, 2026, 3,059 shares of Enovis common stock at $25.79 per share were withheld by the company to satisfy tax withholding obligations tied to restricted stock units.

The footnote explains this was not an open-market sale by Brady but a tax-withholding disposition in connection with net settlement of RSUs. After this transaction, Brady directly owned 101,243 Enovis shares.

Rhea-AI Summary

Enovis CORP’s Senior Vice President and Chief Financial Officer Phillip Benjamin (Ben) Berry reported an automatic share disposition tied to equity compensation. On the Form 4, 2,220 shares of common stock at $25.79 per share were withheld by the company to satisfy tax withholding obligations upon net settlement of restricted stock units, as clarified in the footnote that this does not represent a sale by the reporting person. After this tax-withholding event, Berry’s directly held common stock position is 113,789 shares.

Rhea-AI Summary

Enovis Corp executive Louis Vogt, Group President, Recon, reported a Form 4 transaction involving company common stock. On March 4, 2026, 888 shares were withheld by the company at $25.79 per share to cover tax obligations from the net settlement of restricted stock units. The footnote explains this was a tax-withholding event and not an open-market sale by Vogt. After this withholding, Vogt directly owned 34,608 shares of Enovis common stock.

Rhea-AI Summary

Enovis CORP senior vice president and chief HR officer Patricia A. Lang reported a tax-related share disposition through net settlement of restricted stock units. The company withheld 1,173 shares of common stock at $25.79 per share to cover tax withholding and remittance obligations, and the filing states this does not represent a sale by Lang. After this withholding, she directly holds 53,086 shares of Enovis common stock.

Rhea-AI Summary

Enovis CORP Chief Administrative Officer Oliver Engert reported buying 1,250 shares of common stock in open-market transactions. He purchased 1,000 shares at a weighted average price of $24.77 on March 3, 2026, and 250 shares at $25.10 on March 4, 2026, bringing his direct holdings to 44,890 shares.

The filing notes that the $24.77 price reflects a weighted average for multiple trades completed between $24.64 and $24.89 per share.

Rhea-AI Summary

Enovis CORP senior executive reports routine tax-share withholding. SVP and Chief Legal Officer Bradley J. Tandy had 484 shares of common stock, at a price of $25.47 per share, withheld by the company to cover tax obligations from restricted stock units. After this non‑market tax-withholding disposition, he holds 43,031 shares directly.

Rhea-AI Summary

Enovis CORP senior vice president and chief human resources officer Patricia A. Lang reported a tax-related share disposition. On this Form 4, the company withheld 497 shares of common stock at $25.47 per share to cover tax obligations tied to restricted stock units, and the footnote clarifies this does not represent a sale by her. After this withholding, she directly owned 54,259 shares of Enovis common stock.

Rhea-AI Summary

Enovis CORP executive Louis Vogt reported a small tax-related share disposition. On this Form 4, the company withheld 889 shares of common stock at $25.47 per share to cover tax obligations tied to restricted stock units. This withholding is not an open-market sale, and Vogt continues to hold 35,496 shares directly.

Rhea-AI Summary

Enovis Corp executive reports tax-related share withholding. Group President, P&R Terry D. Ross had 418 shares of Enovis common stock withheld at $25.47 per share to cover tax obligations from restricted stock units. This administrative transaction, described as not representing a sale, leaves Ross holding 35,371 shares directly.

Rhea-AI Summary

Enovis Corp's Chief Administrative Officer buys additional shares. Oliver Engert purchased 1,000 shares of Enovis common stock in an open-market transaction at a price of $25.50 per share. Following this purchase, he directly owns 43,640 shares of Enovis common stock.

Rhea-AI Summary

Enovis CORP director Shirley Brady reported a Form 4 transaction involving 1,492 shares of common stock on February 28, 2026. The shares were withheld by the company at $25.47 per share to cover tax obligations tied to the net settlement of restricted stock units and, according to the disclosure, do not represent a sale by Brady. After this tax-withholding event, Brady’s directly held ownership stood at 104,302 shares of Enovis common stock.

Rhea-AI Summary

Enovis Corp principal accounting officer John Kleckner reported a tax-withholding share disposition related to restricted stock units. The company withheld 315 shares of common stock at $25.47 per share to satisfy tax obligations, which the footnote clarifies does not represent a sale by Kleckner. After this adjustment, he directly holds 11,987 Enovis shares.

Rhea-AI Summary

Enovis Corp Senior Vice President and Chief Financial Officer Phillip Benjamin (Ben) Berry reported a tax-related share withholding. On February 28, 2026, 720 shares of common stock at $25.47 per share were withheld by the company to cover tax obligations, leaving him with 116,009 directly owned shares. The filing states this withholding does not represent an open-market sale by Berry.

Rhea-AI Summary

Enovis Corporation reported that Chief Administrative Officer Oliver Engert received an equity award in the form of restricted stock units on January 5, 2026. The award covers 42,640 shares of common stock at a stated price of $0.00 per share, reflecting a grant rather than an open‑market purchase.

According to the disclosure, these restricted stock units vest in three equal annual installments, beginning on the first anniversary of the grant date. Following this award, Engert is shown as beneficially owning 42,640 shares on a direct basis.

Rhea-AI Summary

Enovis Corp director reports stock acquisition

A director of Enovis Corp (ENOV) reported acquiring 845 shares of the company’s common stock on 12/31/2025. The transaction was reported at a price of $0.00 per share, indicating this was a form of non-cash award such as a grant. Following this transaction, the reporting person beneficially owns 22,140 shares of Enovis common stock, held in direct ownership.